A chalasia is a disorder of esophageal motility defined by absent peristalsis and impaired relaxation of the lower esophageal sphincter in the absence of lower esophageal sphincter obstruction. The pathophysiology involves degeneration of the inhibitory neurons of the myenteric plexus, however, the etiology remains unknown. Achalasia becomes more common with age, and has no sex predilection. [1] [2] [3] [4] [5] [6] [7] Historically, reported annual incidence rates have been 0.5 to 1.2 per 100,000 population (Table 1) , and achalasia accounts for 5% of presentations with dysphagia. 8 These studies of incidence are derived predominantly from retrospective searches of databases of hospital discharge codes and personal communications with gastroenterologists and are likely to be inaccurate. [3] [4] [5] [6] [7] [9] [10] [11] [12] [13] [14] [15] [16] Although some studies quote suspected case detection error rates of 5% to 10%, 6 when case notes have been cross-checked directly with database search results, the error rate is 50% to 66%. 9, 10 More recently, where significant measures have been taken to reduce the case identification error rate, the reported incidence of achalasia has been as high as 1.6 per 100,000 population in both Canadian and Italian populations. 5, 10 Of interest, these reports coincided with the introduction of high-resolution manometry and pressure topography plotting in 2000. 17 This has become the gold standard for diagnosing and classifying achalasia, 18 raising the possibility that, with the introduction of this new technology, there is an improved diagnostic capacity for the identification of patients with achalasia.
In South Australia, during the past decade, the adult South Australian population has had routine esophageal manometry performed at 1 of 3 manometry laboratories for investigation of dysphagia not associated with structural abnormalities. Each laboratory has maintained prospective databases of patient demographics and manometry results. Therefore, in South Australia, it seems possible to identify and validate all diagnosed cases of achalasia by a search of these 3 prospective adult manometry databases. This study was performed to provide information regarding local burden of disease. 
Methods

Esophageal Manometry
During 2004 to 2013, esophageal manometry was performed at 1 of 3 adult laboratories and the patient details and corresponding manometry report were recorded in a prospective database. One additional motility laboratory exists in Adelaide that services the pediatric population, but access to these data proved too difficult for inclusion in our study. To the authors' knowledge, no one in Adelaide offers manometry in the private sector because the Medicare Benefits Schedule fee fails to cover the costs of the procedure. Esophageal pressures were measured using low-and high-resolution manometry (HRM), with motility shown as a continuum of pressure and time using a color display. Manometric data from the Gut Function Laboratory, Department of Gastroenterology and Hepatology, Royal Adelaide Hospital, were acquired between 2004 and 2012 using a Dentsleeve 10-channel water perfused system (Dentsleeve International, Toronto, Canada). Pharyngeal and esophageal channels were spaced 3-cm apart and the remaining 2 channels (channels 7 and 8) incorporated a 6-cm Dentsleeve and proximal gastric side hole (Dentsleeve International). All lumina were perfused with degassed distilled water at a rate of 0.15 mL/min using a lowcompliance perfusion pump. Data were recorded at 25 Hz and analyzed using specialized software (Polygram Net Functional Diagnostics, Skovlunde, Denmark; and Trace version v1.2, Hebbard, Melbourne, Australia). From 2013, data were acquired using either a 16-channel, waterperfused system or a 36-channel, solid-state catheter, with the solid-state system used preferentially for dysphagia referrals. In the water-perfused system, pharyngeal and esophageal channels were spaced 3-cm apart and the remaining 7 channels (channels 10-16) incorporated a 6-cm e-sleeve with 1-cm recording intervals across the lower oesophageal sphincter and a proximal gastric side hole (Dentsleeve International). Data were obtained at 25 Hz and analyzed using the Solar GI HRM System with Quickview Analysis Program (Medical Measurement Systems, Williston, VT). The solid-state catheter is a ManoScan 36-channel assembly with 1-cm pressure sensor spacings (Sierra Scientific/Covidien, a Medtronic company, Los Angeles, CA). Data were obtained at 50 Hz and analyzed with ManoView (Sierra Scientific/Covidien).
Data from the Oesophageal Function Laboratory, Department of Surgery, Royal Adelaide Hospital, were acquired between 2004 and 2010 using a Dentsleeve 8-channel, water-perfused system, as described earlier.
Data were obtained at 40 Hz and analyzed using Acquidata Gastromac (Neomedix Systems, Belrose, New South Wales, Australia). From 2010, data were acquired at 50 Hz using a ManoScan catheter as described earlier and analyzed with ManoView (Sierra Scientific/Covidien).
Data from the Oesophageal Function Laboratory, Investigation and Procedures Unit, Repatriation Hospital, were obtained using the Dentsleeve 16-channel, waterperfused system, as described earlier. Data were recorded at 25 Hz and analyzed using specialized software (Trace Version v1.2).
Case Identification
New manometric diagnoses of achalasia were identified by a search of the 3 prospective South Australian adult manometry databases (Figure 1) . Two databases had the capacity for identification of manometry reports using search functions that extracted reports from the database within a restricted time frame and that contained the word "achalasia" or "non-specific motility disorder." The remaining database had no in-built search function and every manometry report generated between 2004 and 2013 was reviewed. All reports were reviewed and excluded if the met the following criteria:
The report stated "not achalasia," "achalasia excluded," "EGJ (esophagogastric junction) outflow obstruction," or provided no further description of features of achalasia when reporting "nonspecific motility disorder (NSMD)" or "LES [lower esophageal sphincter] relaxation present";
Patients were not residents of South Australia;
Patients had been diagnosed previously with achalasia outside of the specified time frame, and were undergoing post-treatment manometry;
They were duplicate reports (ie, patients who underwent manometry at more than 1 laboratory or on more than 1 occasion). After a diagnosis of achalasia, any subsequent manometry study was excluded to avoid inclusion of prevalence cases A final review was performed to identify patients with pseudo-achalasia (ie, esophageal or junctional cancer). This was achieved by reviewing all endoscopy results (where possible) and patients with pseudoachalasia were excluded.
Data Collection and Statistical Analysis
Data recorded included the date of manometry, patient age, sex, suburb of residence, and the diagnosis details. A diagnosis of achalasia was defined as definite if either the manometry report was conclusive or the report was ambiguous, but the patient was treated clinically as achalasia, and was defined as likely if the manometry report was ambiguous or endoscopy records were unavailable to rule out pseudo-achalasia in a patient aged 50 years and older. An ambiguous report described features of achalasia together with an alternative diagnosis such as diffuse esophageal spasm (DES) or NSMD, or made statements such as "suggestive of achalasia" or "partial expression achalasia."
The annual incidence of achalasia was calculated as new diagnoses per 100,000 population during the period from 2004 to 2013. Adult incidence data are given as a mean in a range: definite to all (definite and likely) cases. Further analysis was performed using all rates. Spearman rank correlation was performed to identify any change in incidence across time or with age. Poisson regression analysis was performed to determine the crude and age-adjusted incidence rate ratios of the male and female, and separately the Capital City and regional/ remote subpopulations, with age adjustment performed using the mean age of identified cases. An independent samples t test was performed to determine the difference in age at diagnosis between subpopulations. Statistical significance was accepted at a P value less than .05. Analyses were performed using the SPSS Statistics Package v17.0 (Chicago, IL), except Poisson regression, which was performed using STATA v14 (StataCorp LP, 2014, College Station, TX).
Age-standardized rates for adults age 18 years and older were determined using the European Standard Population of 1976 19 as follows:
Where P k ¼ standard population in age group. m k ¼ observed incidence rate (cases per 100,000 persons in age group 20-24, 25-30,., 80-84, !85 y).
Results
A total of 350 cases of achalasia were identified during the 10-year period, of which 288 (82%) were classified as definite and 62 (18%) were classified as likely. On average, the annual incidence of achalasia in South Australia was 2.3 to 2.8 per 100,000 population ( Table 2 ). The incidence of achalasia was similar in females (2.55-3.12 per 100,000) compared with that in males (2.05-2.47 per 100,000; definite cases, P ¼ .06; all cases, P ¼ .03; incidence rate ratio, 0.8). The incidence did not change across time during the study period.
The mean age at diagnosis was 62.1 AE 18.1 (SD) years (median, 65.8 y; range, 17.6-99.3 y), and was not different between males and females. Patients who received a definite diagnosis were significantly younger (59.9 AE 1.11) than patients who received a likely diagnosis (72.1 AE 1.9; P < .001).
The incidence of achalasia increased with age (Spearman rho, 0.95; P < .01) (Figure 2 ). The overall agestandardized, all-cases incidence (European Standard Population) range was 2.1 (95% CI, 1.8-2.3) to 2.5 (CI, 2.2-2.7), and 2.3 (CI, 1.9-2.7) for males, and 2.6 (CI, 2.2-2.9) for females. The age-standardized incidence of achalasia was not different between the Capital City (2.5 per 100,000; CI, 2.2-2.8) and regional/remote South Australian (2.0 per 100,000; CI, 1.6-2.5) populations.
Discussion
This study was performed in Australia and reports a high incidence of achalasia at 2.3 to 2.8 cases per 100,000 population. This is almost 50% higher than the current highest reported incidence of 1.6 per 100,000 in both Italian and Canadian populations published since 2000. Figure 2 . The incidence of achalasia increases with age (black, definite cases; grey, likely cases; Spearman rho, 0.95; P < .01).
The population of South Australia is ideally suited for an estimation of the incidence of achalasia. There is ready access to and high uptake of manometry services because all laboratories have acceptable waiting times, and provide services at no out-of-pocket cost to patients. The access for regional and remote patients also is favorable, with government-subsidized travel to Adelaide for manometry services. In our study we identified and validated new cases of achalasia by a search of all 3 prospectively maintained South Australian adult manometry laboratories. This will not have captured patients who have declined further investigation of a swallowing disorder, or patients from South Australia who underwent manometry interstate or overseas. We considered the frequency of travel elsewhere for motility studies to be negligible because the nearest neighboring manometry laboratory is 700 km away.
In recent times there has been an increased recognition of the importance of manometry in investigating benign esophageal disease 20 and an improvement in diagnostic pathways for esophageal diseases. In past studies of incidence, diagnoses of achalasia often have been made using clinical history, barium study, and endoscopy. The gold standard to diagnose achalasia is esophageal manometry, and this is aspired to in South Australian practice, with liberal referral for manometry for both investigation of reflux disease and motility disorders. Consistently, manometry has been identified as providing new information in 87% of patients, 21 and altering the diagnosis in 30% to 44% and management plan in 44% to 66% of patients. 21, 22 Therefore, earlier estimates of the incidence of achalasia performed in the absence of routine esophageal manometry as an adjunct to diagnosis likely would have estimated the burden of disease incorrectly.
During the study period of 2004 to 2013, the manometric definition of achalasia has evolved from the absence of peristalsis, presence of panesophageal pressurization, and impaired LES relaxation to the current Chicago Classification v3.0 definition, which describes cases of achalasia as a median integrated LES relaxation pressure greater than the limit of normal and 100% failed peristalsis or spasm. Type I demonstrates no contractility, type II pan-oesophageal pressurisations and type III spasm. 23 However, it is important to state that it is not the introduction of HRM that is responsible for the increased incidence of achalasia shown in our study. Many of the cases in our study were before the introduction of HRM. It is likely the combination of temporospatial plots (Clouse plots), together with appropriate recording power across the gastroesophageal junction, that have contributed to the observed increase.
An ambiguous interpretation of manometry output is not unique to South Australia. DES evolving into a diagnosis of achalasia on repeat manometry is a welldocumented phenomena, 3, 24, 25 and was observed in the current cohort. Of interest, in this study, patients with ambiguous manometry reports, or likely diagnoses, were significantly older than patients who received a definite diagnosis. This may reflect an age-related deterioration in esophageal motility and function. The prevalence of achalasia, DES, and NSMD all increase with age. [26] [27] [28] [29] We deliberately reported the incidence as a range to ensure we had not overestimated by including ambiguous reports.
The incidence of achalasia increases with age. 1, 3 South Australia has a high proportion (17%) of people aged 65 years and older, and an average age at diagnosis of 62 years, compared with age 50 years in Hong Kong 30 or Korea, 1 and 45 years in Iceland. 9 It follows that an aging population provides a potential explanation for the reported higher incidence. We therefore performed an age standardization using the European Standard Population, unchanged since 1976. The age-standardized rate remained high at 2.1 to 2.5 cases per 100,000 population, therefore the higher reported incidence in this study cannot be explained by an aging population.
It also is unlikely that the higher incidence represents genetic variation between countries. There is little evidence that the incidence of achalasia differs between ethnic populations. A familial pattern in presentation of the disease has never been identified. 4, 9, 31 In South Leicester, there was no difference in incidence between the British and South Asian populations, and in Israel there was no difference between people with different ethnic or residential backgrounds. Only in Singapore has a difference been shown between the Malay, South Asian, and Chinese populations, 16 however, the data set was small, no age-standardization between ethnic populations was performed, 16 and there were significant ethnic differences in health care utilization, thus introducing bias into the case identification process. 32, 33 Furthermore, both Australia and Canada have a broadly genetically diverse population.
It currently is accepted that achalasia has no sex predilection, [1] [2] [3] [4] [5] [6] [7] 26 which is supported by our results. In addition, there was no difference in incidence between the Capital City and regional/remote populations and therefore no potential environmental causes for the disease were identified.
Our study was not perfect. First, it is widely accepted that not all cases of achalasia require manometry for diagnosis, and in some cases manometry is not possible owing to technical reasons (ie, inability for the catheter to traverse the LES). However, omission of these few cases will only underestimate the incidence of achalasia. Second, case note review of all 350 cases was not logistically possible because case notes were spread out over numerous private and public hospitals, as well as private gastroenterologists'/surgeons' consulting rooms. To avoid a false increase of the incidence rate, we retrieved almost all endoscopy reports to exclude patients with pseudo-achalasia. It is possible that some cases were missed.
This study reports a high and what we believe to be a very accurate incidence of achalasia: 2.3 to 2.8 per 100,000 population. This is likely the consequence of improved diagnostic pathways for esophageal motility and reflux disorders, specifically the use of manometry, and data storage in prospectively maintained databases. The unique situation in South Australia of relative geographic isolation and ready access to manometry has allowed accurate identification of cases, with a low probability of missed cases, from all adult manometry laboratories rather than hospital coding. We suspect that the incidence of achalasia worldwide is higher than previously recognized and that future epidemiologic studies using similar methodologies will confirm this.
